The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity

Molecular and Cellular Endocrinology

Volumn 354, Issue 1-2, 2012, Pages 74-84

  vom Saal, Frederick S ^a   Nagel, Susan C ^b   Coe, Benjamin L ^a   Angle, Brittany M ^a   Taylor, Julia A ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

Bisphenol a; Endocrine disrupting chemicals; Metabolic syndrome; Obesity

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADIPOCYTE; ADIPOSE TISSUE; ADULTHOOD; BODY WEIGHT; CELL ACTIVITY; CELL COMMUNICATION; CELL FUNCTION; CHEMICAL INTERACTION; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL STAGE; DISEASE ACTIVITY; DISEASE COURSE; ENDOCRINE DISEASE; ENVIRONMENTAL EXPOSURE; FETUS DISEASE; FETUS GROWTH; FOOD INTAKE; GENITAL SYSTEM DISEASE; HOMEOSTASIS; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRAUTERINE GROWTH RETARDATION; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PLACENTA CIRCULATION; POSTNATAL GROWTH; PRENATAL EXPOSURE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; TISSUE DIFFERENTIATION;

ADIPOCYTES; ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTROGENS; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION; HUMANS; OBESITY; PHENOLS; PHENOTYPE;

EID: 84858278319     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.01.001     Document Type: Review

References (150)

1. Abdelgadir S.E., Resko J.A., Ojeda S.R., Lephart E.D., McPhaul M.J., Roselli C.E. Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brain. Endocrinology 1994, 135:395-401.
2. Adair L.S., Cole T.J. Rapid child growth raises blood pressure in adolescent boys who were thin at birth. Hypertension 2003, 41:451-456.
3. Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 1992, 12:207-233.
4. Akingbemi B.T., Sottas C.M., Koulova A.I., Klinefelter G.R., Hardy M.P. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 2004, 145:592-603.
5. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 2006, 114:106-112.
6. Alonso-Magdalena P., Vieira E., Soriano S., Menes L., Burks D., Quesada I., Nadal A. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ. Health Perspect. 2010, 118:1243-1250.
7. Anderson L.A., McTernan P.G., Barnett A.H., Kumar S. The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J. Clin. Endocrinol. Metab. 2001, 86:5045-5051.
8. Arase S., Ishii K., Igarashi K., Aisaki K., Yoshio Y., Matsushima A., Shimohigashi Y., Arima K., Kanno J., Sugimura Y. Endocrine disrupter bisphenol a increases in situ estrogen production in the mouse urogenital sinus. Biol. Reprod. 2011, 84:734-742.
9. Ashby J., Tinwell H., Haseman J. Lack of effects for low dose levels of bisphenol A (BPA) and diethylstilbestrol (DES) on the prostate gland of CF1 mice exposed in utero. Reg. Tox. Pharm. 1999, 30:156-166.
10. Bailin, P.D., Byrne, M., Lewis, S., Liroff, R., 2008. Public awareness drives market for safer alternatives: bisphenol A market analysis report. Available from: (accessed 20.04.2011). http://www.iehn.org/publications.reports.bpa.php.
11. Baillie-Hamilton P.F. Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Complement. Med. 2002, 8:185-192.
12. Barker D.J. The developmental origins of adult disease. J. Am. Coll. Nutr. 2004, 23:588S-595S.
13. Ben-Jonathan N., Hugo E.R., Brandebourg T.D. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol. Cell Endocrinol. 2009, 304:49-54.
14. Benvenuti, S., Cellai, I., Luciani, P., Deledda, C., Saccardi, R., Mazzanti, B., Dal Pozzo, S., Serio, M., Peri, A., 2011. Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells. J. Endocrinol. Invest. (Online May 19).
15. Blouin K., Nadeau M., Mailloux J., Daris M., Lebel S., Luu-The V., Tchernof A. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E244-E255.
16. Blumberg B. Obesogens, stem cells and the maternal programming of obesity. J. Dev. Origins Health Dis. 2011, 2:3-8.
17. Braun J.M., Hauser R. Bisphenol A and children's health. Curr. Opin. Pediatr. 2011, 23:233-239.
18. Braun J.M., Yolton K., Dietrich K.N., Hornung R., Ye X., Calafat A.M., Lanphear B.P. Prenatal bisphenol A exposure and early childhood behavior. Environ. Health Perspect. 2009, 117:1945-1952.
19. Budge H., Gnanalingham M.G., Gardner D.S., Mostyn A., Stephenson T., Symonds M.E. Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity. Birth Defects Res. C. Embryo Today 2005, 75:193-199.
20. Cederroth C.R., Vinciguerra M., Kühne F., Madani R., Klein M., James R.W., Doerge D.R., Visser T.J., Foti M., Rohner-Jeanrenaud F., Vassalli J.-D., Nef S. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ. Health Perspect. 2007, 115:1467-1473.
21. Chen H.C., Smith S.J., Ladha Z., Jensen D.R., Ferreira L.D., Pulawa L.K., McGuire J.G., Pitas R.E., Eckel R.H., Farese R.V. Increased insulin and leptin sensitivity in mice lacking acyl CoA: diacylglycerol acyltransferase 1. J. Clin. Invest. 2002, 109:1049-1055.
22. Choudhuri S., Cui Y., Klaassen C.D. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol. Appl. Pharmacol. 2010, 245:378-393.
23. Coe B.L., Kirkpatrick J.R., Taylor J.A., vom Saal F.S. A new 'crowded uterine horn' mouse model for examining the relationship between foetal growth and adult obesity. Basic Clin. Pharmacol. Toxicol. 2008, 102:162-167.
24. Colborn, T., Clement, C., 1992. Chemically-Induced alterations in sexual and functional development: the wildlife/human connection. In: Mehlman, M.A. (Ed.), Advances in Modern Environmental Toxicology, Princeton Scientific Publishing C., Inc., Princeton, p. 403.
25. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101:378-384.
26. Coleman R.A., Lee D.P. Enzymes of triacylglycerol synthesis and their regulation. Prog. Lipid Res. 2004, 43:134-176.
27. Cooke P.S., Naaz A. The role of estrogens in adipocyte development and function. Exp. Biol. Med. 2004, 229:1127-1135.
28. Cooke P.S., Heine P.A., Taylor J.A., Lubahn D.B. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol. Cell Endocrinol. 2001, 178:147-154.
29. Cooper S.C., Roncari D.A. 17-beta-estradiol increases mitogenic activity of medium from cultured preadipocytes of massively obese persons. J. Clin. Invest. 1989, 83:1925-1929.
30. Deems R.O., Evans J.L., Deacon R.W., Honer C.M., Chu D.T., Burki K., Fillers W.S., Cohen D.K., Young D.A. Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 1994, 37:1097-1104.
31. Della Seta D., Minder I., Dessi-Fulgheri F., Farabollini F. Bisphenol-A exposure during pregnancy and lactation affects maternal behavior in rats. Brain Res. Bull. 2005, 65:255-260.
32. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 2009, 30:293-342.
33. Dieudonne M.N., Pecquery R., Leneveu M.C., Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000, 141:649-656.
34. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. USA 2007, 104:13056-13061.
35. Donato J., Cravo R.M., Frazao R., Elias C.F. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendocrinology 2011, 93:9-18.
36. EFSA, 2008. Toxicokinetics of Bisphenol A - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing AIDS and Materials in Contact with Food (AFC). In: Authority, E.F.S. (Ed.), (accessed 30.06.2010). http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902017492.htm.
37. Ezure T., Amano S. Increased subcutaneous adipose tissue impairs dermal function in diet-induced obese mice. Exp. Dermatol. 2010, 19:878-882.
38. FDA (2008) FDA Science Board Subcommittee Report on Bisphenol A. Available form: (accessed 4.10.2011). http://www.fda.gov/Food/FoodIngredientsPackaging/ucm166145.htm.
39. Gao Q., Horvath T.L. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E817-E826.
40. Gies A., Heinzow B., Dieter H.H., Heindel J. Bisphenol a workshop of the german federal environment agency - March 30-31, 2009 work group report: public health issues of bisphenol a. Int. J. Hyg. Environ. Health 2009, 212:693-696.
41. Gluckman P.D., Hanson M.A., Morton S.M., Pinal C.S. Life-long echoes - a critical analysis of the developmental origins of adult disease model. Biol. Neonate 2005, 87:127-139.
42. Goldman L., Falk H., Landrigan P.J., Balk S.J., Reigart J.R., Etzel R.A. Environmental pediatrics and its impact on government health policy. Pediatrics 2004, 113:1146-1157.
43. Gregoire F.M. Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. 2001, 226:997-1002.
44. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 1998, 78:783-809.
45. Hager A., Sjostrm L., Arvidsson B., Bjorntorp P., Smith U. Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism 1977, 26:607-614.
46. Hatch E.E., Nelson J.W., Stahlhut R.W., Webster T.F. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int. J. Androl. 2010, 33:324-332.
47. Heindel J.J., vom Saal F.S. Meeting report: batch-to-batch variability in estrogenic activity in commercial animal diets - importance and approaches for laboratory animal research. Environ. Health Perspect. 2008, 116:389-393.
48. Heindel J.J., vom Saal F.S. Overview of obesity and the role of developmental nutrition and environmental chemical exposures. Mol. Cell Endocrinol. 2009, 304:90-96.
49. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. USA 2000, 97:12729-12734.
50. Homma H., Kurachi H., Nishio Y., Takeda T., Yamamoto T., Adachi K., Morishige K., Ohmichi M., Matsuzawa Y., Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J. Biol. Chem. 2000, 275:11404-11411.
51. Honma S., Suzuki A., Buchanan D.L., Katsu Y., Watanabe H., Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod. Toxicol. 2002, 16:117-122.
52. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., vom Saal F.S. Exposure to bisphenol A advances puberty. Nature 1999, 401:763-764.
53. Howdeshell K.L., Peterman P.H., Judy B.M., Taylor J.A., Orazio C.E., Ruhlen R.L., vom Saal F.S., Welshons W.V. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ. Health Perspect. 2003, 111:1180-1187.
54. Hunt P.A. Assessing chemical risk: societies offer expertise. Science 2011, 331:1136.
55. Hunt P.A., Koehler K.E., Susiarjo M., Hodges C.A., Hagan A., Voigt R.C., Thomas S., Thomas B.F., Hassold T.J. Bisphenol A causes meiotic aneuploidy in the female mouse. Curr. Biol. 2003, 13:546-553.
56. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002, 17:2839-2841.
57. Ishido M., Masuo Y., Kunimoto M., Oka S., Morita M. Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J. Neurosci. Res. 2004, 76:423-433.
58. Janesick A., Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res. C. Embryo Today 2011, 93:34-50.
59. Janesick A., Blumberg B. Minireview: PPARgamma as the target of obesogens. J. Steroid Biochem. Mol. Biol. 2011, 147:4-8.
60. Johnson P.R., Hirsch J. Cellularity of adipose depots in six strains of genetically obese mice. J. Lipid Res. 1972, 13:2-11.
61. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. USA 2000, 97:12735-12740.
62. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Misso M.L., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., Simpson E.R. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J. Steroid Biochem. Mol. Biol. 2001, 79:3-9.
63. Joyner J.M., Hutley L.J., Cameron D.P. Estrogen receptors in human preadipocytes. Endocrine 2001, 15:225-230.
64. Kabuto H., Amakawa M., Shishibori T. Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis in mice. Life Sci. 2004, 74:2931-2940.
65. Keith, S.W., Redden, D.T., Katzmarzyk, P.T., Boggiano, M.M., Hanlon, E.C., Benca, R.M., Ruden, D., Pietrobelli, A., Barger, J.L., Fontaine, K.R., Wang, C., Aronne, L.J., Wright, S.M., Baskin, M., Dhurandhar, N.V., Lijoi, M.C., Grilo, C.M., Deluca, M., Westfall, A.O., Allison, D.B., 2006. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int. J. Obes. (Lond), Online June 27.
66. Koehler K.E., Voigt R.C., Thomas S., Lamb B., Urban C., Hassold T.J., Hunt P.A. When disaster strikes: Rethinking caging materials. Lab. Animal 2003, 32:32-35.
67. Krempler F., Breban D., Oberkofler H., Esterbauer H., Hell E., Paulweber B., Patsch W. Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol. 2000, 20:443-449.
68. Landrigan P.J. Children's health and the environment - the first Herbert L. Needleman Award Lecture. Mater. Child Health J. 1997, 1:61-64.
69. Landrigan P., Garg A., Droller D.B. Assessing the effects of endocrine disruptors in the National Children's Study. Environ. Health Perspect. 2003, 111:1678-1682.
70. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
71. Lappas M., Yee K., Permezel M., Rice G.E. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J. Endocrinol. 2005, 186:457-465.
72. Larsen T.M., Toubro S., Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?. Int. J. Obes. Relat. Metab. Disord. 2003, 27:147-161.
73. Lea-Currie Y.R., Monroe D., McIntosh M.K. Dehydroepiandrosterone and related steroids alter 3T3-L1 preadipocyte proliferation and differentiation. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol. 1999, 123:17-25.
74. Marker P.C., Donjacour A.A., Dahiya R., Cunha G.R. Hormonal, cellular, and molecular control of prostatic development. Dev. Biol. 2003, 253:165-174.
75. Markey C.M., Michaelson C.L., Veson E.C., Sonnenschein C., Soto A.M. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ. Health Perspect. 2001, 109:55-60.
76. Markey C.M., Coombs M.A., Sonnenschein C., Soto A.M. Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol. Dev. 2003, 5:67-75.
77. Masuno H., Kidani T., Sekiya K., Sakayama K., Shiosaka T., Yamamoto H., Honda K. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J. Lipid Res. 2002, 43:676-684.
78. Medlock K.L., Forrester T.M., Sheehan D.M. Short-term effects of physiological and pharmacological doses of estradiol on estrogen receptor and uterine growth. J. Recept. Res. 1991, 11:743-756.
79. Melzer D., Rice N.E., Lewis C., Henley W.E., Galloway T.S. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 2010, 5:e8673.
80. Migliaccio S., Newbold R.R., McLachlan J.A., Korach K.S. Alterations in estrogen levels during development affects the skeleton: use of an animal model. Environ. Health Perspect. 1995, 103(Suppl. 7):95-97.
81. Migliaccio S., Newbold R.R., Bullock B.C., Jefferson W.J., Sutton F.G., McLachlan J.A., Korach K.S. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring. Endocrinology 1996, 137:2118-2125.
82. Migliaccio S., Newbold R.R., Teti A., Jefferson W.J., Toverud S.U., Taranta A., Bullock B.C., Suggs C.A., Spera G., Korach K.S. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood. Bone 2000, 27:47-52.
83. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 2003, 144:1474-1480.
84. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J. Atherosclerosis Thrombosis 2007, 14:245-252.
85. Myers J.P., Zoeller T.J., vom Saal F.S. A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ. Health Perspect. 2009, 117:1652-1655.
86. Myers J.P., vom Saal F.S., Akingbemi B.T., Arizono K., Belcher S., Colborn T., Chahoud I., Crain D.A., Farabollini F., Guillette L.J., Hassold T., Ho S.M., Hunt P.A., Iguchi T., Jobling S., Kanno J., Laufer H., Marcus M., McLachlan J.A., Nadal A., Oehlmann J., Olea N., Palanza P., Parmigiani S., Rubin B.S., Schoenfelder G., Sonnenschein C., Soto A.M., Talsness C.E., Taylor J.A., Vandenberg L.N., Vandenbergh J.G., Vogel S., Watson C.S., Welshons W.V., Zoeller R.T. Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ. Health Perspect. 2009, 117:309-315.
87. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., Cooke P.S. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 2002, 34:758-763.
88. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 1997, 105:70-76.
89. Nagel S.C., Hagelbarger J.L., McDonnell D.P. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics. Endocrinology 2001, 142:4721-4728.
90. Nativelle-Serpentini C., Richard S., Seralini G.E., Sourdaine P. Aromatase activity modulation by lindane and bisphenol-A in human placental JEG-3 and transfected kidney E293 cells. Toxicol. In Vitro 2003, 17:413-422.
91. Newbold R.R., Jefferson W.N., Padilla-Banks E., Haseman J. Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects. Reprod. Toxicol. 2004, 18:399-406.
92. Newbold R.R., Padilla-Banks E., Snyder R.J., Jefferson W.N. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res. A. Clin. Mol. Teratol. 2005, 73:478-480.
93. Newbold R.R., Jefferson W.N., Padilla-Banks E. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod. Toxicol. 2007, 24:253-258.
94. Newbold R.R., Padilla-Banks E., Snyder R.J., Phillips T.M., Jefferson W.N. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod. Toxicol. 2007, 23:290-296.
95. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. Int. J. Androl. 2008, 31:201-208.
96. Nikaido Y., Yoshizawa K., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., Tsubura A. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod. Toxicol. 2004, 18:803-811.
97. Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., 2006. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295, 1549-1555.
98. Oken E., Gillman M.W. Fetal origins of obesity. Obes. Res. 2003, 11:496-506.
99. Palanza P., Howdeshell K.L., Parmigiani S., vom Saal F.S. Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ. Health Perspect. 2002, 110:415-422.
100. Palanza P., Gioiosa L., vom Saal F.S., Parmigiani S. Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ. Res. 2008, 108:150-157.
101. Patisaul H.B., Bateman H.L. Neonatal exposure to endocrine active compounds or an ERbeta agonist increases adult anxiety and aggression in gonadally intact male rats. Horm. Behav. 2008, 53:580-588.
102. Pelch, K.E., Carleton, S.M., Phillips, C.L., Nagel, S.C., 2011. Developmental exposure to low dose xenoestrogens alters femur length and tensile strength in adult mice. Biol. Reprod., Online: November 18.
103. Pino, A.M., Rodriguez, J.M., Rios, S., Astudillo, P., Leiva, L., Seitz, G., Fernandez, M., Rodriguez, J.P., 2006. Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin. J. Endocrinol. 191, 715-725.
104. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 2000, 54:3-18.
105. Prins G.S., Ye S.H., Birch L., Ho S.M., Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod. Toxicol. 2011, 31:1-9.
106. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., Vandenbergh J.G., Walser-Kuntz D.R., vom Saal F.S. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 2007, 24:199-224.
107. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
108. Routhledge E.J., White R., Parker M.G., Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERββ. J. Biol. Chem. 2000, 46:35986-35993.
109. Rubin B.S., Murray M.K., Bamassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 2001, 109:657-680.
110. Ruhlen R.L., Howdeshell K.L., Mao J., Taylor J.A., Bronson F.H., Newbold R.R., Welshons W.V., vom Saal F.S. Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice. Environ. Health Perspect. 2008, 116:322-328.
111. Ruhlen R.L., Taylor J.A., Mao J., Kirkpatrick J., Welshons W.V., vomSaal F.S. Choice of animal feed can alter fetal steroid levels and mask developmental effects of endocrine disrupting chemicals. J. Dev. Origins Health Dis. 2011, 2:36-48.
112. Ryan B.C., Vandenbergh J.G. Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Horm. Behav. 2006, 50:85-93.
113. Ryan K.K., Haller A.M., Sorrell J.E., Woods S.C., Jandacek R.J., Seeley R.J. Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010, 151:2603-2612.
114. Sakurai K., Kawazuma M., Adachi T., Harigaya T., Saito Y., Hashimoto N., Mori C. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br. J. Pharmacol. 2004, 141:209-214.
115. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in human maternal-fetal-placental unit. Environ. Health Perspect. 2002, 110:A703-A707.
116. Shioda T., Chesnes J., Coser K.R., Zou L., Hur J., Dean K.L., Sonnenschein C., Soto A.M., Isselbacher K.J. Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc. Natl. Acad. Sci. USA 2006, 103:12033-12038.
117. Skinner M.K., Manikkam M., Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol. Metab. 2010, 21:214-222.
118. Somm E., Schwitzgebel V.M., Vauthay D.M., Camm E.J., Chen C.Y., Giacobino J.P., Sizonenko S.V., Aubert M.L., Huppi P.S. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008, 149:6289-6299.
119. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., Aubert M.L., Huppi P.S. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117:1549-1555.
120. Stahlhut R.W., van Wijngaarden E., Dye T.D., Cook S., Swan S.H. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect. 2007, 115:876-882.
121. Stocker C.J., Arch J.R., Cawthorne M.A. Fetal origins of insulin resistance and obesity. Proc. Nutr. Soc. 2005, 64:143-151.
122. Subbaramaiah K., Hudis C.A., Dannenberg A.J. The prostaglandin transporter regulates adipogenesis and aromatase transcription. Cancer Prev. Res. (Phila) 2011, 4:194-206.
123. Takai Y., Tsutsumi O., Ikezuki Y., Hiroi H., Osuga Y., Momoeda M., Yano T., Taketani Y. Estrogen receptor-mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochem. Biophys. Res. Commun. 2000, 270:918-921.
124. Takai Y., Tsutsumi O., Ikezuki Y., Kamei Y., Osuga Y., Yano T., Taketan Y. Preimplantation exposure to bisphenol A advances postnatal development. Reprod. Toxicol. 2000, 15:71-74.
125. Talsness C., Fialkowski O., Gericke C., Merker H.-J., Chahoud I. The effects of low and high doses of bisphenol A on the reproductive system of female and male rat offspring. Congenital Anomalies 2000, 40:S94-S107.
126. Taylor J.A., Welshons W.V., Vom Saal F.S. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reprod. Toxicol. 2008, 25:169-176.
127. Taylor J.A., Vom Saal F.S., Welshons W.V., Drury B., Rottinghaus G., Hunt P.A., Toutain P.L., Laffont C.M., Vandevoort C.A. Similarity of bisphenol a pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect. 2011, 119:422-430.
128. Thigpen J.E., Setchell K.D., Saunders H.E., Haseman J.K., Grant M.G., Forsythe D.B. Selecting the appropriate rodent diet for endocrine disruptor research and testing studies. ILAR J. 2004, 45:401-416.
129. Thigpen J.E., Setchell K.D., Padilla-Banks E., Haseman J.K., Saunders H.E., Caviness G.F., Kissling G.E., Grant M.G., Forsythe D.B. Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats. Environ. Health Perspect. 2007, 115:1717-1726.
130. Tong Q., Hotamisligil G.S. Molecular mechanisms of adipocyte differentiation. Rev. Endocr. Metab. Disord. 2001, 2:349-355.
131. Tweedale A.C. Uses of 'Good Laboratory Practices' by regulated industry and agencies, and the safety of bisphenol A. J. Epidemiol. Community Health 2011, 65:475-476.
132. Vandenberg L.N., Maffini M.V., Wadia P.R., Sonnenschein C., Rubin B.S., Soto A.M. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology 2007, 148:116-127.
133. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 2007, 24:139-177.
134. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
135. Vandenberg L.N., Chahoud I., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol a. Environ. Health Perspect. 2010, 118:1051-1054.
136. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 2010, 118:1055-1070.
137. vom Saal F.S. Sexual differentiation in litter-bearing mammals: influence of sex of adjacent fetuses in utero. J. Anim. Sci. 1989, 67:1824-1840.
138. vom Saal F.S., Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 2005, 113:926-933.
139. vom Saal F.S., Sheehan D.M. Challenging risk assessment. Forum Appl. Res. Public Policy 1998, 13:11-18.
140. Watson C.S., Jeng Y.J., Kochukov M.Y. Nongenomic signaling pathways of estrogen toxicity. Toxicol. Sci. 2010, 115:1-11.
141. Welshons, W.V., Thayer, K.S., Taylor, J., Judy, B., vom Saal, F.S., 2003. Large effects from small exposures: I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 111, 904-1006.
142. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III: Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
143. Wetherill Y.B., Akingbemi B.T., Kanno J., McLachlan J.A., Nadal A., Sonnenschein C., Watson C.S., Zoeller R.T., Belcher S.M. In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 2007, 24:178-198.
144. Wild S.H., Byrne C.D. Evidence for fetal programming of obesity with a focus on putative mechanisms. Nutr. Res. Rev. 2004, 17:153-162.
145. Xi W., Lee C.K., Yeung W.S., Giesy J.P., Wong M.H., Zhang X., Hecker M., Wong C.K. Effect of perinatal and postnatal bisphenol A exposure to the regulatory circuits at the hypothalamus-pituitary-gonadal axis of CD-1 mice. Reprod. Toxicol. 2011, 31:410-417.
146. Yajnik C.S. Fetal origins of adult disease: where do we stand?. Int. J. Diab. Dev. Countries 2001, 21:42-50.
147. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., Ide T., Kubota N., Terauchi Y., Tobe K., Miki H., Tsuchida A., Akanuma Y., Nagai R., Kimura S., Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 2001, 276:41245-41254.
148. Zalko D., Soto A.M., Dolo L., Dorio C., Rathahao E., Debrauwer L., Faure R., Cravedi J.P. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD-1 mice. Environ. Health Perspect. 2002, 111:309-319.
149. Zhang J.W., Klemm D.J., Vinson C., Lane M.D. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J. Biol. Chem. 2004, 279:4471-4478.
150. Zhao J.W., Gao Z.L., Mei H., Li Y.L., Wang Y. Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation. Am. J. Med. Sci. 2011, 341:460-468.